Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 1, 1998, Pages 134-139

  Smolenski, Albert ^a   Burkhardt, A Mick ^a   Eigenthaler, Martin ^a   Butt, Elke ^a   Gambaryan, Stepan ^a   Lohmann, Suzanne M ^a   Walter, Ulrich ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Atrial natriuretic peptides; cGMP analogs; KT 5823; Protein kinase inhibitors; VASP

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; NITRIC OXIDE; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; QUANTITATIVE DIAGNOSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; HUMANS; ISOENZYMES; NITRIC OXIDE; TRANSFECTION;

EID: 0031842130     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005234     Document Type: Review

References (40)

1. Beltman J, Becker DE, Butt E, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA (1995) Characterization of cyclic nucleolide phosphodiesterases with cGMP analogs: topology of the catalytic domain. Mol Pharmacol 47:330-339
2. Butt E, Walter U (1996) Cyclic nucleotides: meusurement and function. In: Authi K, Watson SP (eds) Platelet function and signal transduction: a practical approach. Oxford University Press, Oxford, pp 259-278
3. Butt E, Bemmelen M van, Fischer L, Walter U, Jastorff B (1990) Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS Lett 263:47-50
4. Butt E, Nolte C, Schulz S, Beltman J, Beavo JA, Jastorff B, Walter U (1992) Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-pCPT-cGMP. Biochem Pharmacol 43:2591-2600
5. Butt E, Geiger J, Jarchau T, Lohmann SM, Walter U (1993) The cGMP-dependent protein kinase - gene, protein, and function. Neurochem Res 18:27-42
6. Butt E, Eigenthaler M, Genieser HG (1994a) Rp-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur J Pharmacol 269:265-268
7. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U (1994b) cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion protein VASP in vitro and in intact human platelets. J Biol Chem 269:14509-14517
8. Butt E, Pöhler D, Genieser HG, Huggins JP, Bucher B (1995) Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET cyclic GMPS. Br J Pharmacol 116:3110-3116
9. Cohen P (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7:353-361
10. Figenthaler M, Nolte C, Halbrügge M, Walter U (1992) Concentration and regulation of cyclic nucleotides, cyclic nucleotide-dependent protein kinases and one of their major substrates in human platelets. Eur J Biochem 205:471-481
11. Eigenthaler M, Ullrich H, Geiger J, Horstrup K, Hönig-Liedl P, Wiebecke D, Walter U (1993) Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase deficient human platelets of chronic myelocytic leukemia. J Biol Chem 268:13526-13531
12. Fiscus RR, Murad F (1988) cGMP-dependent protein kinase activation in intact tissues. Methods Enzymol 159:150-159
13. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, DeJonge HR (1995) Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channel by cGMP-dependent protein kinase II. J Biol Chem 270:26626-26631
14. Glass DB, Cheng H-C, Kemp BE, Walsh DA (1986) Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem 261:12166-12171
15. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, Pilz RB (1996) Regulation of gene expression by cGMP-dependent protein kinase. J Biol Chem 271:4597-4600
16. Gudi T, Lohmann SM, Pilz RB (1997) Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal. Mol Cell Biol 17:5244-5254
17. Hagen V, Dzeja C, Frings S, Bendig J, Krause E, Kaupp UB (1996) Caged compounds of hydrolysis-resistant analogues of cAMP and cGMP: synthesis and application to cyclic nucleotide-gated channels. Biochemistry 35:7762-7771
18. Hidaka H, Kobayashi R (1992) Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32:377-397
19. Kemp BE, Cheng H-C, Walsh DA (1988) Peptide inhibitors of cAMP-dependent protein kinases. Methods Enzymol 159:173-183
20. Koesling D, Bohme E, Schultz G (1991) Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J 5:2785-2791
21. Kramer RH, Tibbs GR (1996) Antagonists of cyclic nucleotide-gated channels and molecular mapping of their site of action. J Neurosci 16:1285-1293
22. Lincoln TM, Komalavilas P, Boerth NJ, MacMillan-Crow LA, Cornwell TL (1995) cGMP signaling through cAMP- and cGMP-dependent protein kinases. Adv Pharmacol 34:305-322
23. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, DeJonge HR (1997) Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 22:307-312
24. Meinecke M, Geiger J, Butt E, Sandberg M, Jahnsen T, Chakrahorty T, Walter U, Jarchau T, Lohmann SM (1994) Human cGMP-dependent protein kinase 1 overexpression increases phosphorylation of an endogenous focal contact associated protein VASP without altering the thrombin-evoked calcium response. Mol Pharmacol 46:283-290
25. ++-current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88:1197-1201
26. North RA, Barnard EA (1997) Nucleotide receptors. Curr Opin Neurobiol 7:346-357
27. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fässler R (1996) Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274:2082-2086
28. Pöhler D, Butt E, Meißner J, Müller S, Lohse M, Walter U, Lohmann S, Jarchau T (1995) Expression, purification, and characterization of the cGMP-dependent protein kinases I and II using the baculovirus system. FEBS Lett 374:419-425
29. Poteet-Smith CE, Corbin JD, Francis SH (1997) The pseudosubstrate sequences alone are not sufficient for potent autoinhibition of cAMP- and cGMP-dependent protein kinases as determined by synthetic peptide analysis. Adv Second Messenger Phosphoprotein Res 31:219-235
30. Ruth P, Wang GX, Boekhoff I, May B, Pfeifer A, Penner R, Korth M, Breer H, Hofmann F (1993) Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci USA 90:2623-2627
31. Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U (1998) Analysis and Regulation of VASP serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273: in press
32. Soff GA, Cornwell TL, Cundiff DL, Gately S, Lincoln TM (1997) Smooth muscle expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100:2580-2587
33. Vaandrager AB, DeJonge HR (1996) Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 157:23-30
34. - channels co-expressed with cGMP-dependent protein kinase type II hut not type I. J Biol Chem 272:4195-4200
35. Vaandrager AB, Edixhoven M, Bot AGM, Kroos MA, Jarchau T, Lohmann SM, Genieser HG, DeJonge HR (1997b) Endogenous type II cGMP-dependent protein kinase exists as a dimer in membranes and can be functionally distinguished from the type I isoforms. J Biol Chem 272:11816-11823
36. Walter U (1989) Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 113:41-88
37. Wedel BJ, Garbers DL (1997) New insights on the functions of the guanylyl cyclase receptors. FEBS Lett 410:29-33
38. Wei J-Y, Cohen ED, Yan Y-Y, Genieser H-G, Barnstahle CJ (1996) Identification of competitive antagonists of the rod photoreceptor cGMP-gated cation channel: PET-substituted cGMP analogues as probes of the cGMP binding site. Biochemistry 35:16815-16823
39. Wei J-Y, Cohen ED, Barnstable CJ (1997) Direct blockade of both cloned rat rod photoreceptor cyclic nucleotide-gated non-selective cation (CNG) channel alpha subunit and native CNG channels from Xenopus rod outer segments by H-8, a non-specific cyclic nucleotide-dependent protein kinase inhibitor. Neurosci Lett 12:37-40
40. Wyatt TA, Pryzwanski KB, Lincoln TM (1991) KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res Commun Chem Pathol Pharmacol 74:3-14